Microbiol. Rev., Sep 1995, 387-405, Vol 59, No. 3
Copyright © 1995, American Society for Microbiology

Immune regulation in Epstein-Barr virus-associated diseases

R Khanna, SR Burrows and DJ Moss
Queensland Institute of Medical Research, Bancroft Centre, Herston, Australia.

Epstein-Barr virus (EBV) is a member of the human herpesvirus family and, like many other herpesviruses, maintains a lifelong latent association with B lymphocytes and a permissive association with stratified epithelium in the oropharynx. Clinical manifestations of primary EBV infection range from acute infectious mononucleosis to an asymptomatic persistent infection. EBV is also associated with a number of malignancies in humans. This review discusses features of the biology of the virus, both in cell culture systems and in the natural host, before turning to the role of the immune system in controlling EBV infection in healthy individuals and in individuals with EBV- associated diseases. Cytotoxic T cells that recognize virally determined epitopes on infected cells make up the major effector arm and control the persistent infection. In contrast, the options for immune control of EBV-associated malignancies are more restricted. Not only is antigen expression restricted to a single nuclear antigen, EBNA1, but also these tumor cells are unable to process EBV latent antigens, presumably because of a transcriptional defect in antigen- processing genes (such as TAP1 and TAP2). The likelihood of producing a vaccine capable of controlling the acute viral infection and EBV- associated malignancies is also discussed.

This article has been cited by other articles:

• Gu, A.-D., Xie, Y.-B., Mo, H.-Y., Jia, W.-H., Li, M.-Y., Li, M., Chen, L.-Z., Feng, Q.-S., Liu, Q., Qian, C.-N., Zeng, Y.-X. (2008). Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology. J. Gen. Virol. 89: 1152-1158 [Abstract] [Full Text]  
• Wu, Y.-M., Yan, J., Ojcius, D. M., Chen, L.-L., Gu, Z.-Y., Pan, J.-P. (2007). Correlation between Infections with Different Genotypes of Human Cytomegalovirus and Epstein-Barr Virus in Subgingival Samples and Periodontal Status of Patients. J. Clin. Microbiol. 45: 3665-3670 [Abstract] [Full Text]  
• Tedeschi, R., Pin, E., Martorelli, D., Bidoli, E., Marus, A., Pratesi, C., Bortolin, M. T., Zanussi, S., Vaccher, E., Dolcetti, R., De Paoli, P. (2007). Serum Antibody Response to Lytic and Latent Epstein-Barr Virus Antigens in Undifferentiated Nasopharyngeal Carcinoma Patients from an Area of Nonendemicity. CVI 14: 435-441 [Abstract] [Full Text]  
• Miles, J. J., Silins, S. L., Brooks, A. G., Davis, J. E., Misko, I., Burrows, S. R. (2005). T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years. Blood 106: 4412-4413 [Full Text]  
• Miles, J. J., Elhassen, D., Borg, N. A., Silins, S. L., Tynan, F. E., Burrows, J. M., Purcell, A. W., Kjer-Nielsen, L., Rossjohn, J., Burrows, S. R., McCluskey, J. (2005). CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection. J. Immunol. 175: 3826-3834 [Abstract] [Full Text]  
• Stone, J. D., Demkowicz, W. E. Jr., Stern, L. J. (2005). HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. Proc. Natl. Acad. Sci. USA 102: 3744-3749 [Abstract] [Full Text]  
• Burrows, J. M., Bromham, L., Woolfit, M., Piganeau, G., Tellam, J., Connolly, G., Webb, N., Poulsen, L., Cooper, L., Burrows, S. R., Moss, D. J., Haryana, S. M., Ng, M., Nicholls, J. M., Khanna, R. (2004). Selection Pressure-Driven Evolution of the Epstein-Barr Virus-Encoded Oncogene LMP1 in Virus Isolates from Southeast Asia. J. Virol. 78: 7131-7137 [Abstract] [Full Text]  
• Salek-Ardakani, S., Lyons, S. A., Arrand, J. R. (2004). Epstein-Barr Virus Promotes Human Monocyte Survival and Maturation through a Paracrine Induction of IFN-{alpha}. J. Immunol. 173: 321-331 [Abstract] [Full Text]  
• Glaser, S. L., Hsu, J. L., Gulley, M. L. (2004). Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 13: 688-697 [Abstract] [Full Text]  
• Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M., Khanna, R. (2003). Promiscuous CTL Recognition of Viral Epitopes on Multiple Human Leukocyte Antigens: Biological Validation of the Proposed HLA A24 Supertype. J. Immunol. 171: 1407-1412 [Abstract] [Full Text]  
• Santodonato, L., D'Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Paola Perrone, M., Andreotti, M., Belardelli, F., Ferrantini, M. (2003). Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response. J. Immunol. 170: 5195-5202 [Abstract] [Full Text]  
• Duraiswamy, J., Sherritt, M., Thomson, S., Tellam, J., Cooper, L., Connolly, G., Bharadwaj, M., Khanna, R. (2003). Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. Blood 101: 3150-3156 [Abstract] [Full Text]  
• Khanolkar, A., Fu, Z., Underwood, L. J., Bondurant, K. L., Rochford, R., Cannon, M. J. (2003). CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells. J. Immunol. 170: 3187-3194 [Abstract] [Full Text]  
• Rose, C., Green, M., Webber, S., Kingsley, L., Day, R., Watkins, S., Reyes, J., Rowe, D. (2002). Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization. J. Clin. Microbiol. 40: 2533-2544 [Abstract] [Full Text]  
• Uda, H., Mima, T., Yamaguchi, N., Katada, Y., Fukuda, M., Fujii, N., Nakamura, K., Saiki, O. (2002). Expansion of a CD28-Intermediate Subset among CD8 T Cells in Patients with Infectious Mononucleosis. J. Virol. 76: 6602-6608 [Abstract] [Full Text]  
• Xu, J., Ahmad, A., Menezes, J. (2002). Preferential Localization of the Epstein-Barr Virus (EBV) Oncoprotein LMP-1 to Nuclei in Human T Cells: Implications for Its Role in the Development of EBV Genome-Positive T-Cell Lymphomas. J. Virol. 76: 4080-4086 [Abstract] [Full Text]  
• Gottschalk, S., Ng, C. Y. C., Perez, M., Smith, C. A., Sample, C., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2001). An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood 97: 835-843 [Abstract] [Full Text]  
• Joseph, A. M., Babcock, G. J., Thorley-Lawson, D. A. (2000). Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils. J. Virol. 74: 9964-9971 [Abstract] [Full Text]  
• Babcock, G. J., Thorley-Lawson, D. A. (2000). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 10.1073/pnas.200366597v1 [Abstract] [Full Text]  
• Fu, Z., Cannon, M. J. (2000). Functional Analysis of the CD4+ T-Cell Response to Epstein-Barr Virus: T-Cell-Mediated Activation of Resting B Cells and Induction of Viral BZLF1 Expression. J. Virol. 74: 6675-6679 [Abstract] [Full Text]  
• Xu, J., Ahmad, A., Jones, J. F., Dolcetti, R., Vaccher, E., Prasad, U., Menezes, J. (2000). Elevated Serum Transforming Growth Factor beta 1 Levels in Epstein-Barr Virus-Associated Diseases and Their Correlation with Virus-Specific Immunoglobulin A (IgA) and IgM. J. Virol. 74: 2443-2446 [Abstract] [Full Text]  
• Rajnavolgyi, E., Nagy, N., Thuresson, B., Dosztanyi, Z., Simon, A., Simon, I., Karr, R. W., Ernberg, I., Klein, E., Falk, K. I. (2000). A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4+ T lymphocytes. Int Immunol 12: 281-293 [Abstract] [Full Text]  
• Xu, J., Ahmad, A., D'Addario, M., Knafo, L., Jones, J. F., Prasad, U., Dolcetti, R., Vaccher, E., Menezes, J. (2000). Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases. J. Immunol. 164: 2815-2822 [Abstract] [Full Text]  
• D’ADDARIO, M., AHMAD, A., XU, J. W., MENEZES, J. (1999). Epstein-Barr virus envelope glycoprotein gp350 induces NF-{kappa}B activation and IL-1{beta} synthesis in human monocytes-macrophages involving PKC and PI3-K. FASEB J. 13: 2203-2213 [Abstract] [Full Text]  
• Tanner, J. E., Alfieri, C. (1999). Epstein-Barr Virus Induces Fas (CD95) in T Cells and Fas Ligand in B Cells Leading to T-Cell Apoptosis. Blood 94: 3439-3447 [Abstract] [Full Text]  
• Chu, P. G., Chang, K. L., Chen, W.-G., Chen, Y.-Y., Shibata, D., Hayashi, K., Bacchi, C., Bacchi, M., Weiss, L. M. (1999). Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA)-4 Mutation in EBV-Associated Malignancies in Three Different Populations. Am. J. Pathol. 155: 941-947 [Abstract] [Full Text]  
• Babcock, G. J., Decker, L. L., Freeman, R. B., Thorley-Lawson, D. A. (1999). Epstein-Barr Virus–infected Resting Memory B Cells, not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients. J. Exp. Med. 190: 567-576 [Abstract] [Full Text]  
• Limaye, A. P., Huang, M.-L., Atienza, E. E., Ferrenberg, J. M., Corey, L. (1999). Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders. J. Clin. Microbiol. 37: 1113-1116 [Abstract] [Full Text]  
• Khanna, R., Sherritt, M., Burrows, S. R. (1999). EBV Structural Antigens, gp350 and gp85, as Targets for Ex Vivo Virus-Specific CTL During Acute Infectious Mononucleosis: Potential Use of gp350/gp85 CTL Epitopes for Vaccine Design. J. Immunol. 162: 3063-3069 [Abstract] [Full Text]  
• Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W. (1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol. 72: 8644-8649 [Abstract] [Full Text]  
• Kienzle, N., Sculley, T. B., Poulsen, L., Buck, M., Cross, S., Raab-Traub, N., Khanna, R. (1998). Identification of a Cytotoxic T-Lymphocyte Response to the Novel BARF0 Protein of Epstein-Barr Virus: a Critical Role for Antigen Expression. J. Virol. 72: 6614-6620 [Abstract] [Full Text]  
• Arkwright, P. D, Makin, G., Will, A. M, Ayres, M., Gokhale, D. A, Fergusson, W. D, Taylor, G M. (1998). X linked lymphoproliferative disease in a United Kingdom family. Arch. Dis. Child. 79: 52-55 [Abstract] [Full Text]  
• Nazaruk, R. A., Rochford, R., Hobbs, M. V., Cannon, M. J. (1998). Functional Diversity of the CD8+ T-Cell Response to Epstein-Barr Virus (EBV): Implications for the Pathogenesis of EBV-Associated Lymphoproliferative Disorders. Blood 91: 3875-3883 [Abstract] [Full Text]  
• Rooney, C. M., Roskrow, M. A., Smith, C. A., Brenner, M. K., Heslop, H. E. (1998). Immunotherapy for Epstein-Barr Virus-Associated Cancers. J Natl Cancer Inst Monogr 1998: 89-93 [Abstract] [Full Text]  
• Thomson, S. A., Burrows, S. R., Misko, I. S., Moss, D. J., Coupar, B. E. H., Khanna, R. (1998). Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4+ Cytotoxic T Lymphocytes: a Novel Approach to Vaccine Design. J. Virol. 72: 2246-2252 [Abstract] [Full Text]  
• Roberge, C. J., McColl, S. R., Larochelle, B., Gosselin, J. (1998). Granulocyte-Macrophage Colony-Stimulating Factor Enhances EBV-Induced Synthesis of Chemotactic Factors in Human Neutrophils. J. Immunol. 160: 2442-2448 [Abstract] [Full Text]  
• Tellam, J., Sherritt, M., Thomson, S., Tellam, R., Moss, D. J., Burrows, S. R., Wiertz, E., Khanna, R. (2001). Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition. J. Biol. Chem. 276: 33353-33360 [Abstract] [Full Text]  
• Babcock, G. J., Thorley-Lawson, D. A. (2000). Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 97: 12250-12255 [Abstract] [Full Text]